Haemonetics (HAE) Tops Q2 EPS by 11c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $101.43 -1.37%
EPS Growth %: 0.0%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: 0.0%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.62, $0.11 better than the analyst estimate of $0.51. Revenue for the quarter came in at $209 million versus the consensus estimate of $207.65 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Core & Main, Inc (CNM) Tops Q3 EPS by 2c ; Offers Guidance
- Independence Realty Trust and Centerspace agree to $8.1B all-stock merger
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
